Invesaro

Stocks TYL Financial statements

Financial statements

TYLER TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TYLER TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7608419351,0861,1171,5921,8501,9522,1382,332
Cost of revenue4014424965705748831,0661,0911,2021,249
Gross profit3593994405175437107848619361,084
Selling, general and administrative165176208258260391
Selling and marketing98.5119136150158149
General and administrative161272267309301316
Operating income138163152156173181214219300358
Interest expense1.0123.328.423.65.935
Other non-operating income-20.73.385.53.131.541.723.3314.637.6
Pre-tax income136163156160175159188198308390
Income tax22-6.128.4113.3-19.8-2.4823.432.345.174.7
Net income114170147147195161164166263316
EBITDA187216214233255316373373443496
EPS, basic3.124.553.843.794.873.953.953.956.177.32
EPS, diluted2.924.323.683.654.693.823.873.886.057.20
Shares, basic (weighted)36.437.338.438.64040.841.54242.643.1
Shares, diluted (weighted)3939.240.140.141.542.242.442.843.543.8

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents36.21861342336043091741657451,015
Short-term investments20.343.244.339.472.252.33710.423.381.8
Receivables200246299374382521577620588639
Other current assets2.2723.412.332.488.158.2410.38.069.41
Total current assets2835215196801,1139648478611,4411,844
Property, plant and equipment124152155172168181173170164160
Lease right-of-use assets01918.739.7513931.435.6
Goodwill6506587548408382,3602,4892,5322,5322,590
Intangible assets2672302773793221,0521,002929832780
Long-term investments82.646.418.57.0510.860.7
Other non-current assets37.433.8465063.286.493.6
Total assets1,3791,6111,7912,1922,6074,7324,6874,6775,1805,639
Accounts payable7.38.176.911514120105146157175
Accrued liabilities5664.766.575.283.1158132159198191
Deferred revenue298299351412461511569633701781
Short-term debt303049.80
Total current liabilities3623714245095648308901,0011,0661,755
Long-term debt1,311957596598
Lease liabilities016.816.336.34839.830.833.3
Other non-current liabilities02.891722.627.431.3
Total liabilities4234204665756212,4082,0631,7391,7921,936
Total debt1,341987646598600
Paid-in capital5576277317399051,0761,2101,3551,5391,616
Retained earnings4366247729171,1121,2741,4381,6041,8672,182
Treasury stock-77.4-60-179-40.2-31.8-25.7-22.8-20.7-18-96.2
Other comprehensive income-0.05-0.05-0.05-0.05-0.05-0.05-0.84-0.33-0.16-0.01
Shareholders' equity9351,1921,3251,6171,9862,3242,6242,9383,3883,703
Total equity9351,1921,3251,6171,9862,3242,6242,9383,3883,703
Total liabilities and equity1,3581,6111,7912,1922,6074,7324,6874,6775,1805,639
Shares outstanding48.148.148.148.148.148.148.148.148.148.1

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income114170147147195161164166263316
Depreciation and amortization49.853.461.876.781.7136159154143138
Stock-based compensation29.737.352.76067.4105103108123151
Deferred income tax-26.4-33.7-5.07-6.09-7.94-13.3-87.2-73.7-30.743.9
Change in receivables-34.8-33.1-50.9-65.7-10.717.6-51.4-39.928.8-61.7
Change in payables0.390.88-2.427.4-0.97-44.9-17.541.510.517.8
Cash from operations192196250255355372381380625654
Capital expenditures-37.7-43.1-27.4-37.2-22.7-33.9-22.5-20.5-20.5-16
Acquisitions-9.39-11.3-178-219-1.29-2,090-164-62.8-1.4-83.7
Purchases of investments-20.3-59.8-116-54.7-157-77.5-29.9-10.6-32.4-228
Sales and maturities of investments16.828.881.270.882.71317149.416122
Cash from investing-50.7-85.4-238-245-98.3-2,091-173-77-67.6-222
Stock issued23.549.874.996.912496.7
Share buybacks-112-7.47-147-17.8-15.5-13000-175
Cash from financing-13839.4-63.688.71141,425-344-31222.2-160
Net change in cash3.06150-51.698.4371-294-135-8.36579271
Free cash flow154153223217332338359360604638
Interest paid0.6117.721.319.23.12.16
Income taxes paid30.2366.821.33.262.2138.514384.240.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $325.57 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin47.2%Gross profit / revenue.
Operating margin15.1%Operating income / revenue.
EBITDA margin21.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin17.3%Pre-tax income / revenue.
Net margin13.4%Net income / revenue.
FCF margin29.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin30.1%Cash from operations / revenue.
Effective tax rate22.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)10.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.6%Net income / average total assets.
Return on invested capital (ROIC)13.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue6.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.7%Capital expenditures / revenue.
D&A / revenue5.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y15.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y15.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y14.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y19.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y18.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y15.6%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y12.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y9.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y20.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y10.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y19.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y23.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y9.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y4.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y19.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y5.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y21.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y13.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y9.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y12.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y13.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y8.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y16.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y1.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.55xCurrent assets / current liabilities.
Quick ratio1.45x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.83x(Cash + short-term investments) / current liabilities.
Liabilities / assets47.8%Total liabilities / total assets.
Interest coverage56.4xOperating income / interest expense.
Working capital$647.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets47.4%(Goodwill + intangible assets) / total assets.
Tangible book value$282.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.42xRevenue / average total assets.
Fixed asset turnover15.2xRevenue / average property, plant and equipment.
Receivables turnover3.35xRevenue / average receivables.
Days sales outstanding109 days365 x average receivables / revenue.
Days payables51 days365 x average accounts payable / cost of revenue.
FCF conversion220.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$7.76Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$58.05Revenue / diluted weighted shares.
FCF per share$17.07Free cash flow / diluted weighted shares.
Operating cash flow per share$17.46Cash from operations / diluted weighted shares.
Book value per share$63.08Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$5.87Tangible book value / shares outstanding.
Cash per share$20.15(Cash + short-term investments) / shares outstanding.
Buybacks / FCF129.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$13.33BShare price x shares outstanding.
Enterprise value$12.36BMarket cap + total debt - cash - short-term investments.
P/E41.1xMarket cap / net income. Only when net income is positive.
P/S5.49xMarket cap / revenue.
P/B4.39xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book47.2xMarket cap / tangible book value, when positive.
P/FCF18.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.2xMarket cap / cash from operations, when positive.
EV/Sales5.09xEnterprise value / revenue.
EV/EBIT33.6xEnterprise value / operating income, when both are positive.
EV/EBITDA24.1xEnterprise value / EBITDA, when both are positive.
EV/FCF17.3xEnterprise value / free cash flow, when both are positive.
FCF yield5.4%Free cash flow / market cap.
Earnings yield2.4%Net income / market cap (the inverse of P/E).
Shareholder yield7.0%(Dividends paid + share buybacks) / market cap.
PEG1.79xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was TYLER TECHNOLOGIES INC's revenue in fiscal 2025?

TYLER TECHNOLOGIES INC reported revenue of $2.33B for fiscal 2025, 9.1% higher than the year before.

Was TYLER TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $315.6M, a net margin of 13.5%.

How much free cash flow did TYLER TECHNOLOGIES INC generate in fiscal 2025?

Cash from operations of $653.5M minus capital expenditures of $16.0M left free cash flow of $637.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TYLER TECHNOLOGIES INC